Parallel Advisors, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$9,668
-10.8%
213
+10.4%
0.00%
Q2 2023$10,835
+24.1%
1930.0%0.00%
Q1 2023$8,729
-10.5%
193
-19.6%
0.00%
Q4 2022$9,756
-53.5%
240
-23.6%
0.00%
-100.0%
Q3 2022$21,000
+10.5%
314
-0.9%
0.00%0.0%
Q2 2022$19,0000.0%317
+4.3%
0.00%0.0%
Q1 2022$19,000
-38.7%
304
-24.8%
0.00%0.0%
Q4 2021$31,000
-16.2%
404
+22.4%
0.00%0.0%
Q3 2021$37,000
-47.1%
330
-23.8%
0.00%
-66.7%
Q2 2021$70,000
+84.2%
433
+40.6%
0.00%
+50.0%
Q1 2021$38,0000.0%308
+25.7%
0.00%0.0%
Q4 2020$38,000
+65.2%
245
-56.0%
0.00%0.0%
Q1 2020$23,000
+4.5%
557
+55.2%
0.00%0.0%
Q4 2019$22,000
+46.7%
3590.0%0.00%
+100.0%
Q3 2019$15,000
-11.8%
3590.0%0.00%
-50.0%
Q2 2019$17,000
+54.5%
359
+79.5%
0.00%0.0%
Q2 2018$11,0002000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2023
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders